These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
124 related articles for article (PubMed ID: 21696891)
21. Enhanced gamma interferon production through activation of Valpha14(+) natural killer T cells by alpha-galactosylceramide in interleukin-18-deficient mice with systemic cryptococcosis. Kawakami K; Kinjo Y; Yara S; Uezu K; Koguchi Y; Tohyama M; Azuma M; Takeda K; Akira S; Saito A Infect Immun; 2001 Nov; 69(11):6643-50. PubMed ID: 11598033 [TBL] [Abstract][Full Text] [Related]
22. Natural killer cells from protein kinase C theta-/- mice stimulated with interleukin-12 are deficient in production of interferon-gamma. Page KM; Chaudhary D; Goldman SJ; Kasaian MT J Leukoc Biol; 2008 May; 83(5):1267-76. PubMed ID: 18263766 [TBL] [Abstract][Full Text] [Related]
23. Kupffer cell-derived interleukin 10 is responsible for impaired bacterial clearance in bile duct-ligated mice. Abe T; Arai T; Ogawa A; Hiromatsu T; Masuda A; Matsuguchi T; Nimura Y; Yoshikai Y Hepatology; 2004 Aug; 40(2):414-23. PubMed ID: 15368446 [TBL] [Abstract][Full Text] [Related]
24. Interleukin-10 suppresses natural killer cell but not natural killer T cell activation during bacterial infection. Scott MJ; Hoth JJ; Turina M; Woods DR; Cheadle WG Cytokine; 2006 Jan; 33(2):79-86. PubMed ID: 16488621 [TBL] [Abstract][Full Text] [Related]
25. Interleukin 18 induces a synergistic enhancement of interferon gamma production in mixed murine spleen cell-tumor cell cultures: role of endogenous interleukin 12. Micallef MJ; Tanimoto T; Kohno K; Ikegami H; Kurimoto M Cancer Detect Prev; 2000; 24(3):234-43. PubMed ID: 10975285 [TBL] [Abstract][Full Text] [Related]
26. Differential cytokine and chemokine gene expression by human NK cells following activation with IL-18 or IL-15 in combination with IL-12: implications for the innate immune response. Fehniger TA; Shah MH; Turner MJ; VanDeusen JB; Whitman SP; Cooper MA; Suzuki K; Wechser M; Goodsaid F; Caligiuri MA J Immunol; 1999 Apr; 162(8):4511-20. PubMed ID: 10201989 [TBL] [Abstract][Full Text] [Related]
27. Intradermal delivery of IL-12 naked DNA induces systemic NK cell activation and Th1 response in vivo that is independent of endogenous IL-12 production. Watanabe M; Fenton RG; Wigginton JM; McCormick KL; Volker KM; Fogler WE; Roessler PG; Wiltrout RH J Immunol; 1999 Aug; 163(4):1943-50. PubMed ID: 10438930 [TBL] [Abstract][Full Text] [Related]
28. A distinct IL-18-induced pathway to fully activate NK T lymphocytes independently from TCR engagement. Leite-De-Moraes MC; Hameg A; Arnould A; Machavoine F; Koezuka Y; Schneider E; Herbelin A; Dy M J Immunol; 1999 Dec; 163(11):5871-6. PubMed ID: 10570271 [TBL] [Abstract][Full Text] [Related]
29. Down-regulation of IL-18 receptor in cancer patients: its clinical significance. Kobashi K; Iwagaki H; Yoshino T; Morimoto Y; Kohka H; Kodama M; Nishibori M; Akagi T; Tanaka N Anticancer Res; 2001; 21(5):3285-93. PubMed ID: 11848485 [TBL] [Abstract][Full Text] [Related]
30. Interleukin 18 induces the sequential activation of natural killer cells and cytotoxic T lymphocytes to protect syngeneic mice from transplantation with Meth A sarcoma. Micallef MJ; Tanimoto T; Kohno K; Ikeda M; Kurimoto M Cancer Res; 1997 Oct; 57(20):4557-63. PubMed ID: 9377569 [TBL] [Abstract][Full Text] [Related]
31. Prevention of injury-induced suppression of T-cell immunity by the CD1d/NKT cell-specific ligand alpha-galactosylceramide. Tulley JM; Palmer JL; Gamelli RL; Faunce DE Shock; 2008 Feb; 29(2):269-77. PubMed ID: 17693934 [TBL] [Abstract][Full Text] [Related]
32. Enhancement of neutrophil function by interleukin-18 therapy protects burn-injured mice from methicillin-resistant Staphylococcus aureus. Kinoshita M; Miyazaki H; Ono S; Inatsu A; Nakashima H; Tsujimoto H; Shinomiya N; Saitoh D; Seki S Infect Immun; 2011 Jul; 79(7):2670-80. PubMed ID: 21536791 [TBL] [Abstract][Full Text] [Related]
33. Sphingosine kinase inhibitor suppresses IL-18-induced interferon-gamma production through inhibition of p38 MAPK activation in human NK cells. Cheon S; Song SB; Jung M; Park Y; Bang JW; Kim TS; Park H; Kim CH; Yang YH; Bang SI; Cho D Biochem Biophys Res Commun; 2008 Sep; 374(1):74-8. PubMed ID: 18602364 [TBL] [Abstract][Full Text] [Related]
34. Protective effect of NK1.1(+) T cells as well as NK cells against intraperitoneal tumors in mice. Kawamura T; Seki S; Takeda K; Narita J; Ebe Y; Naito M; Hiraide H; Abo T Cell Immunol; 1999 May; 193(2):219-25. PubMed ID: 10222065 [TBL] [Abstract][Full Text] [Related]
35. Rapid generation of potent and tumor-specific cytotoxic T lymphocytes by interleukin 18 using dendritic cells and natural killer cells. Tanaka F; Hashimoto W; Okamura H; Robbins PD; Lotze MT; Tahara H Cancer Res; 2000 Sep; 60(17):4838-44. PubMed ID: 10987295 [TBL] [Abstract][Full Text] [Related]
36. Critical contribution of IFN-gamma and NK cells, but not perforin-mediated cytotoxicity, to anti-metastatic effect of alpha-galactosylceramide. Hayakawa Y; Takeda K; Yagita H; Kakuta S; Iwakura Y; Van Kaer L; Saiki I; Okumura K Eur J Immunol; 2001 Jun; 31(6):1720-7. PubMed ID: 11385616 [TBL] [Abstract][Full Text] [Related]
37. Role of NK1.1+ cells in experimental listeriosis. NK1+ cells are early IFN-gamma producers but impair resistance to Listeria monocytogenes infection. Teixeira HC; Kaufmann SH J Immunol; 1994 Feb; 152(4):1873-82. PubMed ID: 8120395 [TBL] [Abstract][Full Text] [Related]
38. Endotoxin fails to induce IFN-gamma in endotoxin-tolerant mice: deficiencies in both IL-12 heterodimer production and IL-12 responsiveness. Balkhy HH; Heinzel FP J Immunol; 1999 Mar; 162(6):3633-8. PubMed ID: 10092824 [TBL] [Abstract][Full Text] [Related]
39. Characterization of two F4/80-positive Kupffer cell subsets by their function and phenotype in mice. Kinoshita M; Uchida T; Sato A; Nakashima M; Nakashima H; Shono S; Habu Y; Miyazaki H; Hiroi S; Seki S J Hepatol; 2010 Nov; 53(5):903-10. PubMed ID: 20739085 [TBL] [Abstract][Full Text] [Related]
40. Enhanced antitumor response by divergent modulation of natural killer and natural killer T cells in the liver. Subleski JJ; Hall VL; Back TC; Ortaldo JR; Wiltrout RH Cancer Res; 2006 Nov; 66(22):11005-12. PubMed ID: 17108139 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]